共查询到18条相似文献,搜索用时 109 毫秒
1.
目的:论述以血管内皮生成因子(VEGF)及其受体VEGFR为靶点的肺癌的研究现状,探讨VEGF及VEGFR与肺癌发生及发展的关系,为肺癌抗血管生成的治疗提供新的药物作用途径。方法:依据近年国内外的相关文献,进行归纳和分析,对VEGF及肺癌发生相关系统进行研究,并在此基础上,提出肺癌抗血管治疗的新思路。结果:研究发现,在肺癌的发生及发展过程中,VEGF出现过量表达。为达到抑制其促血管生成的作用,以VEGF/VEGFR为靶点,研制抑制VEGF活性的药物或干扰VEGFR的药物,可在一定程度上实现通过抑制相关抗血管生成治疗肺癌的目的。结论:利用新的抗血管途径有望在肺癌治疗中研发出新药,提高肺癌治疗效果。 相似文献
2.
肿瘤细胞通过刺激新生血管生成来满足对营养及供氧的不断增长的需求,因此,肿瘤组织生长对于新生血管形成的依赖性使得抗血肿瘤管生成已经成为肿瘤学基础研究与临床治疗领域中最吸引人的策略之一.在众多的促血管生成因子中,血管内皮生长因子(VEGF)及其受体VEGFR2(鼠和人中也分别称为Flk-1和KDR)对于与肿瘤生长、转移及复发相关的血管生成是至关重要的.此外,通过打破肿瘤组织自身介导的免疫耐受与逃避,主动免疫治疗已成为一种崭新的抗肿瘤治疗方法.通过将这两种策略联合应用,抗血管生成主动免疫治疗使得更加有效地抑制肿瘤血管生成成为可能.这种免疫治疗与抗血管生成的联合应用有望成为一种有良好前景的研究方案.本文总结了通过打破VEGF/VEGFR2信号通路实现的抗肿瘤血管生成主动免疫治疗方面最新研究进展.本文讨论了旨在抑制血管生成的三种不同形式的抗肿瘤疫苗-细胞疫苗、蛋白质/多肽疫苗及基因/DNA疫苗,以及这一领域未来的研究方向. 相似文献
3.
研究表明,肿瘤的生长转移和新血管的生成有密切关系,其中血管内皮细胞生长因子(vascular endothelial growth factor,VEGF)及其信号途径在肿瘤血管生成中起关键作用。阻断该途径的任何环节均可有效抑制肿瘤血管的生成,进而抑制肿瘤的生长和转移。近年来,已有多种以VEGF/VEGFR为靶点的抗肿瘤血管生成药物投入临床应用,其中bevacizumab为第一个获批上市的抗肿瘤血管生成药物。继bevacizumab后,一种以基因工程手段获得的人Fc融合蛋白Zaltrap也成功在美国上市,这种杂交分子的药代动力学明显优于单克隆抗体,能更好的遏制肿瘤血管的发生并消退已形成的肿瘤血管。在肿瘤的临床治疗中,Zaltrap比bevacizumab显示出更大的优势。此外,VEGFC/D Trap及小分子酪氨酸激酶抑制剂也能有效抑制肿瘤血管的生成。在此对以VEGF/VEGFR为靶点的抗肿瘤血管生成药物进行综述。 相似文献
4.
VEGF与肿瘤血管生成及其在抗肿瘤药物开发中的应用 总被引:2,自引:0,他引:2
肿瘤血管生成在肿瘤的形成和转移过程中起到很重要的作用,众多的血管生成因子和抑制因子在肿瘤血管生成中起到调控作用,而血管生成因子(VEGF)是其中很重要的一类,通过研究其在肿瘤血管形成过程的调节机制,找到了一条有效的预防和治疗肿瘤的新途径。本文就肿瘤血管生成、VEGF家族的特性、VEGF在抗肿瘤药物开发中的应用做一综述。 相似文献
5.
6.
血管生成因子研究进展 总被引:3,自引:0,他引:3
近年来,随着基因重组技术和蛋白质工程技术的完善和发展,一类可促进新生血管生成的蛋白多肽被相继发现,它们被统称为血管生成因子(angiogenicfactor,AF)[1]。目前已被分离纯化和克隆的有:成纤维细胞生长因子(fibroblastgrowthfac tor,FGF)、血管内皮细胞生长因子(vascularendothelialcellgrowthfactor,VEGF)、血小板衍生生长因子(plateletderivedgrowthfactor,PDGF)、转化生长因子(transforminggro… 相似文献
7.
8.
9.
查尔酮是一种天然化合物,为多种药用植物的有效成分,国内外已经陆续报道了其抗肿瘤活性。查尔酮类化合物抗肿瘤作用靶点较为广泛,但缺乏系统性的文献综述。因此,该文将针对查尔酮类化合物作为潜在的抗肿瘤药物靶向抑制IκB激酶、硫氧还蛋白还原酶、微管蛋白、血管表皮生长因子、p53通路来发挥抗肿瘤作用的研究进行综述,以期为肿瘤的治疗提供更多的理论参考。 相似文献
10.
血管生成在肿瘤的发生发展过程中起着非常重要的作用.促血管生成因子及其受体可以通过调节血管生成促进肿瘤发生发展.因此,发现和开发靶向血管生成因子药物已经成为治疗肿瘤的重要策略.近年来,天然产物因其结构多样、毒副作用低及作用机制独特等优势已然成为开发抗肿瘤药物的主要来源.本文归纳阐述了近年来靶向血管生成因子具有抗肿瘤活性的... 相似文献
11.
肺癌是世界上主要癌症杀手之一,大部分肺癌病人都死于肿瘤转移所引起的并发症.由于现在大部分的肺癌病人预后不佳,因此寻找新方法、新途径治疗尤为重要.抗血管生成是目前的肿瘤治疗研究热点之一.对目前以抗血管内皮生成因子为手段的肺癌治疗方面的研究作一综述. 相似文献
12.
目的研究血管内皮生长因子(VEGF)及其受体2(VEGFR2)在实验性左侧精索静脉曲张大鼠睾丸中的表达和定位,探讨精索静脉曲张中VEGF和VEGFR2的可能作用。方法通过部分结扎左肾静脉建立大鼠实验性左侧精索静脉曲张模型,于术后2周和4周取材,采用免疫组化法检测VEGF、VEGFR2在睾丸上的表达变化。结果 ELV2周与4周组大鼠两侧睾丸中VEGF蛋白表达均上调,但ELV组间VEGF蛋白表达没有明显变化;ELV2周组大鼠睾丸中VEGFR2蛋白的表达与对照组比较增强,而4周组比对照组和2周组均显著增强。结论实验性左侧精索静脉曲张对VEGF、VEGFR2蛋白的表达有影响,说明它们与男性不育可能有一定的关系。 相似文献
13.
Hengxiang Cui Yeqi Wang Huizhe Huang Wenjie Yu Min Bai Long Zhang Brad A. Bryan Yuan Wang Jian Luo Dali Li Yanlin Ma Mingyao Liu 《The Journal of biological chemistry》2014,289(50):34871-34885
Angiogenesis, the formation of new blood vessels from pre-existing ones, is essential for development, wound healing, and tumor progression. The VEGF pathway plays irreplaceable roles during angiogenesis, but how other signals cross-talk with and modulate VEGF cascades is not clearly elucidated. Here, we identified that Gpr126, an endothelial cell-enriched gene, plays an important role in angiogenesis by regulating endothelial cell proliferation, migration, and tube formation. Knockdown of Gpr126 in the mouse retina resulted in the inhibition of hypoxia-induced angiogenesis. Interference of Gpr126 expression in zebrafish embryos led to defects in intersegmental vessel formation. Finally, we identified that GPR126 regulated the expression of VEGFR2 by targeting STAT5 and GATA2 through the cAMP-PKA-cAMP-response element-binding protein signaling pathway during angiogenesis. Our findings illustrate that GPR126 modulates both physiological and pathological angiogenesis through VEGF signaling, providing a potential target for the treatment of angiogenesis-related diseases. 相似文献
14.
Rui Zeng Xiao-fei Jiang Yu-cheng Chen Yuan-ning Xu Song-hong Ma Zhi Zeng Rui Liu Ou Qiang Xian Li 《Cytotechnology》2014,66(4):655-665
The purpose of this study was to determine the relationship between VEGF and mini-TyrRS/mini-TrpRS in angiogenesis in hypoxic culture and to begin to comprehend their mechanism in angiogenesis. We designed a VEGF gene silencing assay by using lentivirus vectors, and then western blotting was used to determine the protein expression of VEGF, VEGFR2 and pVEGFR2 in three groups in hypoxic culture at 3, 6, 12, or 24 h: (1) untransfected human umbilical vein endothelial cells (HUVECs) (Control); (2) pGCSIL-GFP lentivirus vector-transduced HUVECs (Mock); and (3) pGCSIL-shVEGF lentivirus vector-transduced HUVECs (Experimental). We also detected the effects of mini-TyrRS/mini-TrpRS peptides on HUVEC proliferation, migration and tube formation after lentivirus vector transfection and VEGFR2 antibody injection. The results indicated that expression of the mini-TyrRS protein was increased, whereas that of mini-TrpRS was specifically decreased in hypoxic culture both in control and mock groups. However, this trend in protein levels of mini-TyrRS and mini-TrpRS was lost in the experimental group after transduction with the pGCSIL-shVEGF lentivirus vector. The protein expression of VEGF was increased in hypoxic culture both in control and mock groups. After transduction with the pGCSIL-shVEGF lentivirus vector, the protein level of VEGF was noticeably decreased in the experimental group; however, for VEGFR2, the results showed no significant difference in VEGFR2 protein expression in any of the groups. For pVEGFR2, we found a distinct trend from that seen with VEGF. The protein expression of pVEGFR2 was sharply increased in hypoxic culture in the three groups. The addition of mini-TyrRS significantly promoted proliferation, migration and tube formation of HUVECs, while mini-TrpRS inhibited these processes in both control and mock groups in hypoxic culture. However, these effects disappeared after transduction with the pGCSIL-shVEGF lentivirus vector in the experimental group, but no significant difference was observed after VEGFR2 antibody injection. The protein expression of VEGF is similar to that of mini-TyrRS in hypoxic culture and plays an important role in the mini-TyrRS/mini-TrpRS-stimulated proliferation, migration and tube formation of HUVECs in hypoxia. These results also suggest that the change in mini-TyrRS and mini-TrpRS expression in hypoxic culture is not related to VEGFR2 and that some other possible mechanisms, are involved in the phosphorylation of VEGFR2. 相似文献
15.
16.
VEGF、VEGFR2在青春期大鼠睾丸、附睾及附睾精子上的表达 总被引:2,自引:0,他引:2
目的通过对血管内皮生长因子(VEGF)及其受体VEGFR2在青春期大鼠睾丸及附睾表达的研究,探讨其在雄性生殖器官中的作用。方法采用免疫组化法检测VEGF、VEGFR2在SD大鼠睾丸和附睾的表达定位,用免疫荧光法检测它们在大鼠附睾精子上的表达定位。结果VEGF及VEGFR2在青春期大鼠睾丸和附睾组织中均有表达。在睾丸中,VEGF主要表达于精原细胞胞质、精子细胞发育中的顶体、Sertoli细胞胞质及精子残余体内,Leydig细胞胞质也有阳性表达;VEGFR2主要表达于精子细胞发育中的顶体和间质细胞胞质。在附睾中,VEGF表达于附睾管上皮所有主细胞胞质内;而VEGFR2表达于附睾管头段和尾段上皮主细胞胞质内,体段免疫染色阴性。免疫荧光显示,VEGF与VEGFR2都与精子头部顶体、尾部颈段、中段和主段相结合,末段未见阳性荧光。结论VEGF及VEGFR2在大鼠的睾丸和附睾中均有表达,其表达定位具有细胞特异性和区域特异性,提示其可能在大鼠睾丸精子发生和附睾精子成熟中发挥重要作用。 相似文献
17.
Afsaneh Sadremomtaz Farzad Kobarfard Kamran Mansouri Laleh Mirzanejad 《Journal of receptor and signal transduction research》2013,33(5-6):432-441
AbstractBackground: Vascular endothelial growth factor (VEGF) A and B are endothelial cell mitogens whose ligation to VEGFR1/VEGFR2 drives tumor angiogenesis and metastasis, and epithelial-mesenchymal transition (EMT). Blockade of these signaling axes could be obtained by disturbing the interactions between VEGFA and/or VEGFB with VEGFR1 and/or VEGFR2.Methods: A 14-mer peptide (VGB) that recognizes both VEGFR1 and VEGFR2 were investigated for its inhibitory effects on the VEGF‐induced proliferation and migration using MTT and scratch assay, respectively. Downstream signaling pathways were also assessed by quantitative estimation of gene and protein expression using real-time PCR and immunohistochemistry (IHC).Results: We investigated the inhibitory effects of VGB on downstream mediators of metastasis, including epithelial-cadherin (E-cadherin), matrix metalloprotease-9 (MMP-9), cancer myelocytomatosis (c-Myc), and nuclear factor-κβ (NF-κβ), and migration, comprising focal adhesion kinase (FAK) and its substrate Paxilin. VGB inhibited the VEGF‐induced proliferation of human umbilical vein endothelial cells (HUVECs), 4T1 and U87 cells in a time- and dose-dependent manner and migration of HUVECs. Based on IHC analyses, treatment of 4T1 mammary carcinoma tumor with VGB led to the suppression of p-AKT, p-ERK1/2, MMP-9, NF-κβ, and activation of E-cadherin compared with PBS-treated controls. Moreover, quantitative real-time PCR analyses of VGB-treated tumors revealed the reduced expression level of FAK, Paxilin, NF-κβ, MMP-9, c-Myc, and increased expression level of E-cadherin compared to PBS-treated controls.Conclusions: Our results demonstrated that simultaneous blockade of VEGFR1/VEGFR2 is an effective strategy to fight solid tumors by targeting a wider range of mediators involved in tumor angiogenesis, growth, and metastasis. 相似文献
18.
目的探讨胃癌组织中PTEN、vascular endothelial growthfactor(VEGF)基因表达及其与肿瘤侵袭转移的关系。方法用RT-PCR和免疫组化方法检测胃癌、淋巴结转移组织中PTEN、VEGF mRNA和蛋白表达;用CD34检测肿瘤细胞微血管数。结果PTEN和VEGF mRNA表达阳性率在正常胃黏膜为76.5%与0.0%、胃癌组织为30.9%与69.1%、淋巴结转移组织23.6%与74.5%;PTEN和VEGF蛋白阳性率在正常胃黏膜为76.5%与0.0%、胃癌组织27.9%与82.4%、淋巴结转移组织16.3%与91.0%;胃癌组织中新生血管呈浸润生长,以淋巴结转移组织中明显。胃癌组织PTEN mRNA和蛋白低于正常胃黏膜(P〈0.01),VEGF高于正常胃黏膜(P〈0.01),PTEN与VEGF表达负相关(P〈0.05),VEGF表达与新生血管形成正相关(P〈0.05)。结论PTEN基因失活和VEGF的过表达与新生血管形成相关,可能是通过调节包括VEGF在内的血管生成因子而在血管形成中起作用。 相似文献